Le conseil n'étant pas majoritairement composé de membres libres de conflits d'intérêts potentiels, seul la candidature du membre considéré indépendant sera accepté sur les deux propositions de nomination au conseil (résolutions 5 et6).
En raison de montants demandés considérés comme excessifs et de l'absence de suspension en periode d'offre publique, les différentes résolutions portant sur des augmentations de capital ne seront pas soutenues (résolutions 11 à 15).
Par ailleurs, il est regrettable que le rapport spécial des commissaires aux comptes sur les conventions et engagements réglementés ne soit pas communiqué (résolution 4).
Crossject SA is a France-based company that designs and develops medical injection systems. The Company specializes in needle-free, pre-filled, single-use injection systems for intradermal, subcutaneous and intramuscular applications for pharmaceutical companies. Is also has a pipeline and three drugs in the preclinical or clinical phase of research. The Company's products, which are based on well-known injectable drugs (chemicals and biologics), are designed to enhance patients' safety, compliance and comfort. Crossject's first ZENEO SUPERGENERIC product is expected to reach the market in the year 2015. The Company has industrial partnerships with Hirtenberger and Recipharm.
Founded in 1995, Proxinvest is an independent proxy firm supporting the engagement and proxy analysis processes of investors. Proxinvest mission is to analyse corporate governance practices and resolutions proposed at general meetings of listed firms.
Proxinvest main services are :
Proxinvest has been a pioneer and champion of good corporate governance and has grown into a recognised expert in the field.
Proxinvest is independently-owned and only works for investors : Proxinvest does not provide consulting services to the companies it covers, mitigating related risks to its clients and ensuring the independence of our analysis. As a result Proxinvest is able to take a robust, independent, engaged and unconflicted view of the companies in which our clients invest.
As Managing Partner of Expert Corprate Governance Service Ltd (ECGS), Proxinvest has built a large network of corporate governance experts to support clients in corporate governance analysis worldwide.
No major changes after the release of the FY19 report EPS CHANGE CHANGE IN EPS2019 : € -0.49 vs -0.48 ns 2020 : € -0.32 vs -0.34 ns No major changes to our forecasts. The only ones come from the integration of the detailed FY19 numbers which marginally impact our forecasts, with hardly any change to our target price.
A director at Crossject bought 710,750 shares at 1.763EUR and the significance rating of the trade was 77/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board me...
Résolutions 8 et 10 relativement aux rémunérations 2019 de Monsieur Philippe Rosio, Président Directeur Général et de Madame Arline Gaujal-Kempler, Directeur Général Délégué: Selon la société, les résolutions consistent au fait d’approuver l’absence de toute rémunération perçue par les dirigeants au sein de la société. Cependant, ceux-ci sont rémunérés par le biais de la société GEST qui facture à Foncière Inéa des prestations de management et de gestion administrative pour un montant de 4 138 000 €, soit 13,3% des loyers nets et 10% du résultat net part du groupe (résolution 5). Ainsi, bien q...
General: The AGM is to be held in the form of a virtual AGM in accordance with the German Law to Mitigate the Consequences of the COVID-19 Pandemic. The physical presence of shareholders or their authorised proxies is not possible. The voting rights may therefore be exercised solely by postal vote or by granting authority to the proxies designated by the Company. One of the major shareholders, Roland Oetker, is the former President and since 2008 the Honorary President of DSW, the local partner of ECGS. This report has been prepared using standard ECGS guidelines. Evotec was founded 19...
In general, Danske Bank is in compliance with the Danish regulations relating to organisation and procedures of the Annual General Meeting. Under ITEM 4f it is proposed to re-appoint Ms. Carol Sergeant as Vice Chairman of the board of directors. Although she is considered independent, ECGS does NOT approve of the re-appointment of any board members who were part of the board of directors at the time of the money laundering scandal in Estonia. Accordingly, ECGS recommends to vote OPPOSE. Under ITEM 7 authorisation is sought to repurchase own shares. Although the authority requested woul...
Unfortunately, this report is not available for the investor type or country you selected.Browse all ResearchPool reports
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.